The release of PTH and synthesis of 1,25-dihydroxyvitamin D3 (1,25D) from 25-hydroxyvitamin D3 are key endocrine events that counteract hypocalcemia, leading to urinary and intestinal Ca2+ (re)absorption and bone Ca2+ mobilization [6]. The gene discussed is PTH; the disease is Hypocalcemia.